相关实验视频
Updated: Jan 31, 2026

06:01
A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
10.0K
在结肠直肠癌中,关于腹转移有什么值得知道的?
Michał Stańczak1,2, Wiesław Kruszewski1,2, Maciej Ciesielski1,2
1Oncological Surgery Department, Medical University of Gdansk, Gdańsk, Poland.
Frontiers in surgery
|January 30, 2026
概括
结肠直肠癌 (CRC) 产生的腹膜转移 (PM) 存在挑战,但诊断和腹膜内疗法的进步为选定的患者提供了更好的生存率. 多学科的护理和持续的研究是改善PM的CRC治疗结果的关键.
科学领域:
- 在瘤学瘤学.
- 手术瘤学手术瘤学
- 胃肠病学 胃肠病学
背景情况:
- 由结直肠癌 (CRC) 引起的腹转移 (PM) 是一个严重的临床挑战,预后不佳.
- 甲状腺细菌以同步和超时的速度发生,腹膜是肝脏之后的第二个最常见的转移部位.
- 患PM的危险因素包括右侧结肠瘤,BRAF突变和粘膜组织学.
研究的目的:
- 审查PM的CRC患者的病理生理学,危险因素,诊断策略和治疗选择.
- 突出了PM的诊断,手术技术和腹腔内治疗的最新进展.
- 讨论腹癌指数 (PCI) 和新兴治疗方法的预后意义.
主要方法:
- 关于结肠直肠癌腹转移的当前文献的综述.
- 分析包括CT,MRI,PET/CT和腹腔镜在内的诊断方式.
- 评估治疗策略,如细胞还原性手术 (CRS),高热性腹腔内化疗 (HIPEC) 和加压腹腔内气溶化疗 (PIPAC).
主要成果:
- 带有或没有高热性腹腔内化学疗法 (HIPEC) 的细胞还原性手术 (CRS) 改善了受限PCI的选定患者的生存率.
- 腹癌指数 (PCI) 对于预后和治疗决策至关重要.
- 像PIPAC这样的新兴疗法显示出希望,而HIPEC的作用仍在争论中.
结论:
- 优化CRC与PM的结果需要由多学科团队在专业中心进行管理.
- 以生物标志物为基础的个性化治疗策略对于改善患者预后至关重要.
- 对分子预测因子和新型药物输送的持续研究对于推进医疗保健至关重要.
相关概念视频
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
744
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
744
Peritoneal Dialysis I: Introduction and Procedure
3.0K
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
3.0K
Peritoneal Dialysis III: Nursing Management
794
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
794
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
506
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
506
Cancer
54.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
54.2K
What is Cancer?
14.4K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.4K

